NCT07475689

Brief Summary

Lumbar facet joint-mediated chronic low back pain is a common cause of disability. Radiofrequency ablation (RFA) of the lumbar medial branches is an established interventional pain treatment. Different cannula designs may influence lesion geometry and clinical outcomes. This prospective randomized study aims to compare the clinical outcomes of conventional cannulas and sidekick cannulas used during lumbar medial branch radiofrequency ablation. Patients with chronic lumbar facet joint pain who meet inclusion criteria will be randomly assigned to receive RFA using either a conventional cannula or a sidekick cannula technique. The primary objective is to evaluate pain reduction following the procedure. Secondary outcomes include functional improvement and duration of pain relief during follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 16, 2026

Completed
Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

March 6, 2026

Last Update Submit

March 11, 2026

Conditions

Keywords

Back painFacet joint painSidekick cannulaChronic back pain

Outcome Measures

Primary Outcomes (1)

  • Change in pain intensity (Numeric Rating Scale)

    Change in pain intensity measured by Numeric Rating Scale (NRS) Pain intensity will be measured using the Numeric Rating Scale (NRS) ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate greater pain intensity.

    Baseline to 6 months

Secondary Outcomes (1)

  • Functional improvement

    6 months

Study Arms (2)

Conventional Cannula

ACTIVE COMPARATOR

Lumbar medial branch radiofrequency ablation performed using a conventional radiofrequency cannula.

Procedure: Lumbar Medial Branch Radiofrequency AblationDrug: Triamcinolone (20 g)Drug: bupivacain 0.5% 2mlDevice: conventional radiofrequency cannul

Sidekick Cannula

EXPERIMENTAL

Lumbar medial branch radiofrequency ablation performed using a sidekick radiofrequency cannula.

Procedure: Lumbar Medial Branch Radiofrequency AblationDrug: Triamcinolone (20 g)Drug: bupivacain 0.5% 2mlDevice: sidekick radiofrecueny cannula

Interventions

Lumbar medial branch radiofrequency ablation performed for chronic lumbar facet-mediated pain. The procedure is performed under fluoroscopic guidance .

Conventional CannulaSidekick Cannula

Triamcinolone acetonide administered after ablation as part of the post-procedural injection mixture.

Conventional CannulaSidekick Cannula

Bupivacaine 0.5% administered after ablation as part of the post-procedural injection mixture.

Conventional CannulaSidekick Cannula

standard straight radiofrequency cannula used during lumbar medial branch radiofrequency ablation

Conventional Cannula

sidekick radiofrequeny cannula designed to preduce a larger lesion during lumbaar brach medial branch radiofrequeny ablation

Sidekick Cannula

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Chronic lumbar facet-mediated low back pain lasting more than 3 months
  • Failure of conservative treatment including physical therapy and medical management
  • Positive diagnostic medial branch block
  • Patients scheduled for lumbar medial branch radiofrequency ablation

You may not qualify if:

  • Previous lumbar radiofrequency ablation at the same level
  • Coagulopathy or anticoagulant therapy that cannot be discontinued
  • Local infection at the procedure site
  • Severe spinal deformity or instability
  • Pregnancy
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulhane Training and Research Hospital, Department of Anesthesiology and Reanimation

Ankara, 06010, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Low Back PainBack Pain

Interventions

Triamcinolone

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
This is a single-blind randomized study. Participants and outcome assessors are blinded to the cannula type used during lumbar medial branch radiofrequency ablation. The physician performing the procedure is aware of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology Specialist

Study Record Dates

First Submitted

March 6, 2026

First Posted

March 16, 2026

Study Start

August 1, 2024

Primary Completion

August 1, 2025

Study Completion

September 24, 2025

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations